We observed a reduction in p-Smad3 in murine BMSCs treated with JTE013 or the S1PR2 shRNA and infected with Aa (Figure 3A,F) compared to JTE013 or the S1PR2 shRNA-treated BMSCs without Aa infection. This evidence concerns the gene S1PR2 and infection.